期刊文献+

茶碱类药物在支气管哮喘治疗中的合理应用 被引量:8

Rational Use of Theophylline in the Treatment of Bronchial Asthma
下载PDF
导出
摘要 目的研究分析支气管哮喘使用茶碱类药物治疗的临床效果。方法根据2012年3月~2014年3月我院的97例支气管哮喘患者,将这些患者分成对照组和实验组,对照组使用常规治疗,实验组使用常规治疗和茶碱类药物治疗,比较分析两组的临床治疗情况。结果实验组显效34例,好转11例,无效3例,总有效率为93.75%;对照组显效26例,好转10例,无效13例,总有效率为73.47%。实验组的临床治疗有效率比对照组高,两组结果差异具有统计学意义(P〈0.05)。结论茶碱类药物对支气管哮喘患者具有非常好的治疗效果,可以起到抗炎、调节免疫力、扩张支气管等作用,且副作用小。 Objective To study the clinical effect of the treatment of bronchial asthma with theophylline. Methods 97 cases of bronchial asthma patients were divided into control group and experimental group in our hospital from March 2012 to March 2014, the control group were treated with routine therapy, we used conventional treatment and the0phylline drugs, compared with two groups of clinical treatment. Results In the experimental group, 34 cases were markedly effective, 11 cases improved, 3 cases ineffective, the total effective rate was 93.75%, while the control group was 26 cases, 10 cases improved, 13 cases ineffective, the total effective rate was 73.47%. The clinical therapeutic efficacy of the experimental group was higher than that of the control group, and there was significant difference between the two groups (P〈0.05). Conclusion Theophylline drugs have very good therapeutic effect in patients with bronchial asthma. It can play a role in anti inflammation, immune regulation, and expansion of the bronchus.
作者 刘丽娟
出处 《中国继续医学教育》 2015年第22期95-96,共2页 China Continuing Medical Education
关键词 茶碱类药物 支气管哮喘 应用价值 Theophylline drugs, Bronchial asthma, Application value
  • 相关文献

参考文献3

二级参考文献41

  • 1徐蓝,孙云,谢强敏.哮喘治疗新靶点——RhoA/Rho激酶及其抑制剂开发[J].世界临床药物,2009,30(11):679-683. 被引量:2
  • 2JiongYANG,WeiGUO,Han-xiangNIE,Su-pingHU.Interleukin-12 was not involved in promotion of T helper cell differentiation induced by theophylline[J].Acta Pharmacologica Sinica,2004,25(12):1666-1670. 被引量:3
  • 3吴峰,黄峥慧,李志鹰.缓释茶碱对哮喘患者PEF值改善效果的探讨[J].临床肺科杂志,2006,11(6):725-726. 被引量:1
  • 4Zeki AA,Kenyon NJ,Goldkorn T. Statin drugs,metabolic pathways,and asthma:a therapeutic opportunity needing further research[J].Drug Metab Lett,2011.40-44.
  • 5Takeda N,Kondo M,Ito S. Role of RhoA inactivation in reduced cell proliferation of human airway smooth muscle by simvastatin[J].American Journal of Respiratory Cell and Molecular Biology,2006.722-729.
  • 6Kim DY,Ryu SY,Lim JE. Anti-inflammatory mechanism of simvastatin in mouse allergic asthma model[J].European Journal of Pharmacology,2007.76-86.
  • 7Samson KT,Minoguchi K,Tanaka A. Inhibitory effects of fluvastatin on cytokine and chemokine production by peripheral blood mononuclear cells in patients with allergic asthma[J].Clinical and Experimental Allergy,2006.475-482.
  • 8Dichtl W,Dulak J,Frick M. HMG-CoA reductase inhibitors regulate inflammatory transcription factors in human endothelial and vascular smooth muscle cells[J].Arteriosclerosis,Thrombosis,and Vascular Biology,2003.58-63.
  • 9Paumelle R,Blanquart C,Briand O. Acute Antiinflammatory Properties of Statins Involve Peroxisome Proliferator-Activated Receptor-α via Inhibition of the Protein Kinase C Signaling Pathway[J].Circulation Research,2006.361-369.
  • 10Serrano CV Jr,Yoshida VM,Venturinelli ML. Effect of simvastatin on monocyte adhesion molecule expression in patients with hypercholesterolemia[J].Atheroclerosis,2001.505-512.

共引文献38

同被引文献51

引证文献8

二级引证文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部